US Deputy Chief of Mission visits MUWRP’s PEPFAR supported sites in Koome and Kimmi Islands as PEPFAR marks 20 years anniversary
US Deputy Chief of Mission visits MUWRP’s PEPFAR supported sites in Koome and Kimmi Islands as PEPFAR marks 20 years anniversary
By: Hadijah Mwanje As the Presidential Emergency Plan for AIDS Relief (PEPFAR) marks 20 years of saving millions of lives, preventing millions of new infections, and changing the course of the HIV epidemic, the US Deputy Chief of Mission paid a courtesy visit to Koome HCIII and Kimmi islands (all…
Visit Japanese National Institute of Infectious Diseases
Visit from the Japanese National Institute of Infectious Diseases By Jesca Nawatti On Wednesday 18th January 2023, Makerere University Walter Reed Project (MUWRP) hosted a delegation from the Embassy of Japan in Uganda. The visiting team included staff from the Japanese Embassy in Uganda and officials from the Japanese National…
PRE-QUALIFICATION NOTICE
The Supply Chain Section of the Makerere University Walter Reed Project invites reputable firms/Companies, organizations and individuals interested in being prequalified for various supplies/goods, works and services as mentioned below for the Financial Years 2023/2024 and 2024/2025. You are to pay a non-refundable fee of one hundred thousand Uganda shillings…
REQUEST FOR PROPOSALS FROM PROSPECTIVE CBOs SUB GRANTEES
BACKGROUND FOR THE GRANT: MUWRP is Implementing a comprehensive HIV/ AIDS prevention care and treatment program in collaboration with Local Government structures, Faith Based Organizations, Community Based Organizations, Ministry of Health, Ministry of Gender Labour and Social Development and other partners in the districts of Buikwe, Buvuma, Kayunga and Mukono.…
We have started Part B of the Schistosomiasis Vaccine trial Protocol in Kasenyi
By: Jesca Nawatti Towards the end of July, 2021 our Clinic Research team kicked off pre-screening activities for Schistosomiasis Part B Protocol, a randomized, controlled, double blind clinical trial assessing the safety, reactogenicity and immunogenicity of a candidate vaccine against intestinal schistosomiasis in healthy adult volunteers living in the S.…
Digital Connectivity at Fort Portal Regional Referral Hospital improving Day by Day – Thanks to the JMEDICC Programme
By Stephen Mugamba For the past 5 years, the Joint Mobile Emerging Disease Intervention Clinical Capability (JMEDICC) has established clinical research capabilities for clinical trials during filovirus (Ebola/Marburg) outbreaks, allowing testing of new therapeutics and medical countermeasures. The project is a collaboration between US Naval Medical Research Center, United States…
The TSS team carrying out routine maintenance of the IT infrastructure in Fort Portal
By Stephen Mugamba The world of clinical care is currently undergoing a rapid wave of technological advancement, especially to address the challenges of providing clinical care during epidemics and management of highly infectious diseases. This wave of technological advancement has applications during the conduct of clinical trials in outbreak settings.For…
The US Ambassador, Natalie E. Brown vists MUWRP
By: Stephen Mugamba On the 16th March 2021, Makerere University Walter Reed Project (MUWRP), was privileged to host the new US Ambassador to Uganda, Natalie E. Brown. In respect of standard operating procedures to prevent the spread of COVID-19, the visit was attended by handful of delegates, including; the Walter Reed Army…
MUWRP Hosts the New US WRAIR Commander, Col. Clinton K. Murray
By Stephen Mugamba & Jesca Nawatti Makerere University Walter Reed Project (MUWRP) was privileged to host the new Commander of the Walter Reed Army Institute of Research (WRAIR), Colonel (Col.) Clinton K. Murray. Due to the current COVID-19 pandemic restrictions, the one hour meeting was held virtually on Thursday 11th…
Makerere University Walter Reed Project (MUWRP) is conducting a Schistosomiasis Vaccine Trial – Part B is underway
By: Jesca and StephenAs part of MUWRP’s large research profile, we are conducting a Randomized Controlled Double-Blind Phase I/II Dose-escalation Clinical Trial to assess the safety, reactogenicity and immunogenicity of a candidate vaccine against intestinal schistosomiasis in healthy adult volunteers living in the S. Mansoni endemic areas in and around…